• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪组织脂蛋白脂肪酶和激素敏感性脂肪酶。家族性混合性高脂血症和胰岛素抵抗综合征中的对比发现。

Adipose tissue lipoprotein lipase and hormone-sensitive lipase. Contrasting findings in familial combined hyperlipidemia and insulin resistance syndrome.

作者信息

Reynisdottir S, Angelin B, Langin D, Lithell H, Eriksson M, Holm C, Arner P

机构信息

Lipid Laboratory, Department of Medicine and Research Center, Karolinska Institute, Huddinge University Hospital, Sweden.

出版信息

Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):2287-92. doi: 10.1161/01.atv.17.10.2287.

DOI:10.1161/01.atv.17.10.2287
PMID:9351402
Abstract

The metabolism of free fatty acids (FFA) is altered in two common atherosclerosis-promoting disorders: familial combined hyperlipidemia (FCHL) and insulin resistance syndrome (IRS). It has been suggested that these two conditions may have a common etiology. The enzymes lipoprotein lipase (LPL) and hormone-sensitive lipase (HSL) are rate-limiting steps for the turnover of fatty acids in adipose tissue, because they hydrolyze extracellular triglycerides in lipoproteins (LPL) and intracellular triglycerides in adipocytes (HSL). The present study was undertaken to simultaneously determine the activities of LPL and HSL in subcutaneous adipose tissue from male patients with FCHL and IRS. LPL and HSL activity was investigated in 10 nonobese FCHL patients and compared with 10 matched healthy nonobese subjects, and in 8 essentially normolipidemic IRS patients (who did not have overt diabetes mellitus) and compared with 9 nonobese matched control subjects. LPL activity was 43% lower in patients with IRS (P < .0005), as compared with control subjects, but HSL activity was not significantly different in the two groups, On the other hand, HSL activity was decreased by 45% in FCHL patients (P < .01), as compared with control subjects, but LPL activity was not significantly different in FCHL patients and the control group. In conclusion, triglyceride metabolism in adipose tissue is altered in both FCHL and IRS. However, the abnormalities observed involve impaired function of LPL in IRS and impaired function of HSL in FCHL, suggesting separate etiologies for the altered lipolysis in these conditions, at least in male subjects.

摘要

在两种常见的促动脉粥样硬化疾病——家族性混合型高脂血症(FCHL)和胰岛素抵抗综合征(IRS)中,游离脂肪酸(FFA)的代谢发生了改变。有人提出这两种病症可能有共同的病因。脂蛋白脂肪酶(LPL)和激素敏感性脂肪酶(HSL)这两种酶是脂肪组织中脂肪酸周转的限速步骤,因为它们分别水解脂蛋白中的细胞外甘油三酯(LPL)和脂肪细胞中的细胞内甘油三酯(HSL)。本研究旨在同时测定FCHL和IRS男性患者皮下脂肪组织中LPL和HSL的活性。对10名非肥胖FCHL患者的LPL和HSL活性进行了研究,并与10名匹配的健康非肥胖受试者进行比较;同时对8名基本血脂正常的IRS患者(无明显糖尿病)的LPL和HSL活性进行了研究,并与9名非肥胖匹配对照受试者进行比较。与对照受试者相比,IRS患者的LPL活性降低了43%(P <.0005),但两组的HSL活性没有显著差异。另一方面,与对照受试者相比,FCHL患者的HSL活性降低了45%(P <.01),但FCHL患者和对照组的LPL活性没有显著差异。总之,FCHL和IRS患者的脂肪组织中甘油三酯代谢均发生了改变。然而,观察到的异常情况是,IRS患者中LPL功能受损,FCHL患者中HSL功能受损,这表明这些情况下脂肪分解改变的病因不同,至少在男性受试者中是这样。

相似文献

1
Adipose tissue lipoprotein lipase and hormone-sensitive lipase. Contrasting findings in familial combined hyperlipidemia and insulin resistance syndrome.脂肪组织脂蛋白脂肪酶和激素敏感性脂肪酶。家族性混合性高脂血症和胰岛素抵抗综合征中的对比发现。
Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):2287-92. doi: 10.1161/01.atv.17.10.2287.
2
C3, hormone-sensitive lipase, and peroxisome proliferator-activated receptor gamma expression in adipose tissue of familial combined hyperlipidemia patients.家族性混合性高脂血症患者脂肪组织中C3、激素敏感性脂肪酶和过氧化物酶体增殖物激活受体γ的表达
Metabolism. 2002 May;51(5):664-70. doi: 10.1053/meta.2002.32032.
3
Reduced hormone-sensitive lipase activity is not a major metabolic defect in Finnish FCHL families.激素敏感性脂肪酶活性降低并非芬兰家族性混合型高脂血症(FCHL)家族中的主要代谢缺陷。
Atherosclerosis. 2000 Dec;153(2):373-81. doi: 10.1016/s0021-9150(00)00410-x.
4
Fasting and post-prandial adipose tissue lipoprotein lipase and hormone-sensitive lipase in obesity and type 2 diabetes.肥胖和 2 型糖尿病患者空腹和餐后脂肪组织脂蛋白脂肪酶和激素敏感脂肪酶。
J Endocrinol Invest. 2011 May;34(5):e110-4. doi: 10.1007/BF03347469. Epub 2010 Oct 4.
5
In vivo modulation of plasma free fatty acids in patients with familial combined hyperlipidemia using lipid-lowering medication.使用降脂药物对家族性混合性高脂血症患者血浆游离脂肪酸进行体内调节。
J Clin Endocrinol Metab. 2002 Apr;87(4):1576-80. doi: 10.1210/jcem.87.4.8408.
6
Evidence of insulin resistant lipid metabolism in adipose tissue in familial combined hyperlipidemia, but not type 2 diabetes mellitus.家族性混合性高脂血症患者脂肪组织中存在胰岛素抵抗性脂质代谢的证据,但2型糖尿病患者不存在。
Atherosclerosis. 2002 Oct;164(2):337-46. doi: 10.1016/s0021-9150(02)00109-0.
7
Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients.肥胖患者体重减轻期间生长激素治疗对脂肪和肌肉组织中脂蛋白脂肪酶及激素敏感性脂肪酶活性和基因表达的调节作用
Metabolism. 2000 Jul;49(7):906-11. doi: 10.1053/meta.2000.6738.
8
Coordinated regulation of hormone-sensitive lipase and lipoprotein lipase in human adipose tissue in vivo: implications for the control of fat storage and fat mobilization.体内人体脂肪组织中激素敏感性脂肪酶和脂蛋白脂肪酶的协同调节:对脂肪储存和脂肪动员控制的影响。
Adv Enzyme Regul. 1995;35:163-78. doi: 10.1016/0065-2571(94)00011-q.
9
No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes in Finnish families.在芬兰家庭中,没有证据表明家族性混合性高脂血症与编码脂解酶的基因之间存在联系。
Arterioscler Thromb Vasc Biol. 1997 May;17(5):841-50. doi: 10.1161/01.atv.17.5.841.
10
Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.家族性混合性高脂血症中脂肪细胞脂解激活受损。
J Clin Invest. 1995 May;95(5):2161-9. doi: 10.1172/JCI117905.

引用本文的文献

1
Familial Combined Hyperlipidemia: Myth or Reality?家族性混合型高脂血症:虚构还是现实?
Curr Atheroscler Rep. 2025 Apr 1;27(1):45. doi: 10.1007/s11883-025-01289-9.
2
Downregulation of adipose LPL by PAR2 contributes to the development of hypertriglyceridemia.蛋白酶激活受体 2(PAR2)下调脂肪组织脂蛋白脂肪酶(LPL)导致甘油三酯血症的发生。
JCI Insight. 2024 Jul 8;9(13):e173240. doi: 10.1172/jci.insight.173240.
3
Nrf2 Signaling Pathway as a Key to Treatment for Diabetic Dyslipidemia and Atherosclerosis.Nrf2 信号通路作为治疗糖尿病血脂异常和动脉粥样硬化的关键。
Int J Mol Sci. 2024 May 27;25(11):5831. doi: 10.3390/ijms25115831.
4
Changes in Lipid Metabolism Enzymes in Rat Epididymal Fat after Chronic Central Leptin Infusion Are Related to Alterations in Inflammation and Insulin Signaling.慢性中枢性瘦素输注后大鼠附睾脂肪代谢酶的变化与炎症和胰岛素信号改变有关。
Int J Mol Sci. 2023 Apr 11;24(8):7065. doi: 10.3390/ijms24087065.
5
Gene Expression Analysis of Environmental Temperature and High-Fat Diet-Induced Changes in Mouse Supraclavicular Brown Adipose Tissue.环境温度和高脂肪饮食诱导的小鼠锁骨上褐色脂肪组织变化的基因表达分析。
Cells. 2021 Jun 2;10(6):1370. doi: 10.3390/cells10061370.
6
Hypoglycemic and hypolipidemic effects of two mangrove plants in a streptozotocin-induced animal model of diabetes.两种红树林植物在链脲佐菌素诱导的糖尿病动物模型中的降血糖和降血脂作用
J Adv Vet Anim Res. 2020 Aug 3;7(3):421-428. doi: 10.5455/javar.2020.g437. eCollection 2020 Sep.
7
Fasting and post-prandial adipose tissue lipoprotein lipase and hormone-sensitive lipase in obesity and type 2 diabetes.肥胖和 2 型糖尿病患者空腹和餐后脂肪组织脂蛋白脂肪酶和激素敏感脂肪酶。
J Endocrinol Invest. 2011 May;34(5):e110-4. doi: 10.1007/BF03347469. Epub 2010 Oct 4.
8
A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia.一种系统遗传学方法揭示了美国转录因子1、脂肪酸去饱和酶3以及家族性混合型高脂血症的其他因果候选基因。
PLoS Genet. 2009 Sep;5(9):e1000642. doi: 10.1371/journal.pgen.1000642. Epub 2009 Sep 11.
9
Translational regulation of lipoprotein lipase in adipocytes: depletion of cellular protein kinase Calpha activates binding of the C subunit of protein kinase A to the 3'-untranslated region of the lipoprotein lipase mRNA.脂肪细胞中脂蛋白脂肪酶的翻译调控:细胞蛋白激酶Cα的缺失激活蛋白激酶A的C亚基与脂蛋白脂肪酶mRNA的3'非翻译区的结合。
Biochem J. 2008 Jul 15;413(2):315-22. doi: 10.1042/BJ20071559.
10
Hormone-sensitive lipase is reduced in the adipose tissue of patients with type 2 diabetes mellitus: influence of IL-6 infusion.2型糖尿病患者脂肪组织中激素敏感性脂肪酶减少:白细胞介素-6输注的影响。
Diabetologia. 2005 Jan;48(1):105-12. doi: 10.1007/s00125-004-1598-x. Epub 2004 Dec 18.